News
Noel Courage and Nyrie Israelian coauthored the article “The scope of Canadian patented drug price review narrows”, published by The Life Sciences Lawyer
February 4, 2022
Noel Courage and Nyrie Israelian coauthored the article “The scope of Canadian patented drug price review narrows”, published by The Life Sciences Lawyer.
“The Canadian Patented Medicine Prices Review Board regulates prices of patented medicines. Any thread of connection between an approved medicine and a Canadian patent can trigger the Board’s jurisdiction to review price”.
Click here to read full article.
This article was first published in The Life Sciences Lawyer magazine, Issue 6, 2022.
